2020 Annual Meeting | C35 - Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

Date Saturday 04/25/20

Time 01:30 PM - 03:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ruple S. Laughlin, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to demonstrate how to approach a neuromuscular patient electrodiagnostically with appropriate nerve conduction studies and needle examination to evaluate suspected peripheral neuropathy, myopathy, mononeuropathies, and radiculopathies. The program will emphasize case-based application of knowledge acquired in Clinical EMG I.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:30 PM - 01:35 PM	Introduction	Introduction Ruple S. Laughlin, MD, FAAN
01:35 PM - 02:10 PM	Speaker	Case Based Studies in EMG: Peripheral Neuropathy Ruple S. Laughlin, MD, FAAN
02:10 PM - 02:45 PM	Speaker	Case Based Studies in EMG: Myopathy and Neuromuscular Junction Charles Kassardjian, MD
02:45 PM - 03:20 PM	Speaker	Case-Based Studies in EMG: Mononeuropathies, Plexopathies, and Radiculopathies John C. Kincaid, MD, FAAN
03:20 PM - 03:30 PM	Q&A	Questions and Answers
03:30 PM - 04:00 PM	Discussion	Continuing the Conversation

Faculty Disclosures
John C. Kincaid, MD, FAAN	Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for strongbridge pharmaceuticals. Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for social security administrstion. The institution of Dr. Kincaid has received research support from Ionis Pharmaceuticals. Dr. Kincaid has received publishing royalties from a publication relating to health care. Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a medical expert for disability cases with social security administrstion. Dr. Kincaid has a non-compensated relationship as a I am the historian of the Board of Directors for this organization with AANEM that is relevant to AAN interests or activities.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Charles Kassardjian, MD	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.

��ɫ��

��ɫ��